VCYT Veracyte, Inc. SERVICES-MEDICAL LABORATORIES Best Medical Labs Stocks 2026 →

Veracyte (VCYT) Stock: Buy, Sell, or Hold?

$24.06
-1.86 (-7.18%) β–Ό
5d: -52.16% 30d: -45.34% 90d: -46.15%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
47/100
Position
OVERSOLD
30-Day Fair Range
$35.27 – $51.72
Position: OVERSOLD
Forward P/E & Valuation
13.9x CHEAP
vs 23.7x historical avg
Wall Street Target
$52.10
+116.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$21.91 / $52.76
Trend: Downtrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: VCYT is down 52.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When VCYT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$33.69
Based on -3.7% avg growth
INTRINSIC VALUE TODAY
$20.92
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.7x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: VCYT is currently trading at $24.06, which is considered oversold relative to its 30-day fair value range of $35.27 to $51.72. From a valuation perspective, the stock is trading at a discount (Forward PE: 13.9) compared to its historical average (23.7). Remarkably, the market is currently pricing in an annual earnings decline of 16.2% over the next few years. This pessimistic expectation contrasts with the company's recent 58.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, VCYT is in a downtrend. Immediate support is located at $21.91, while resistance sits at $52.76. Short-term momentum is weak, with the stock down 7.2% recently.

Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $52.10 (+116.5%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $35.27 - $51.72
Company Quality Score 47/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 74.8%

Trading Range & Key Levels

30-Day Trading Range $35.27 - $51.72
Current vs Trading Range OVERSOLD
Support Level $21.91
Resistance Level $52.76
Current Trend Downtrend
Technical data as of Nov 10, 2026

Protect Your Profits

Holding VCYT? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-7.2%)
  • BULLISH: Trading 116.5% below Wall St target ($52.10)
  • WARNING: Composite score 47/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 13.94
Wall Street Target $52.10 (+116.5%)
Revenue Growth (YoY) 15.1%
Earnings Growth (YoY) 58.3%
Profit Margin 21.8%
Valuation Discount vs History -16.2% cheaper
PE vs Historical 13.9 vs 23.7 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -16.2% (market-implied from PE analysis)
1-Year Target $21.65 (-10%)
2-Year Target $19.49 (-19%)
3-Year Target $17.54 (-27%)
3-Yr Target (if PE normalizes) (PE: 14β†’24) $29.81 (+24%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: -11.3%) $24.98 (+4%)
Base: (SPY PE: 13.9, Growth: -11.3%) $17.54 (-27%)
Bear: (PE: 11.9, Growth: -11.3%) $14.91 (-38%)
πŸ“ˆ Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 16.83 | Current EPS (TTM): $1.54
Bull Case $31.95 (+33%)
Analyst growth 12.1%, PE expands to 18.5
Base Case $29.04 (+21%)
Market implied 12.1%, PE stable at 16.8
Bear Case $17.63 (-27%)
Severe decline -20.0%, PE contracts to 14.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
πŸ’‘ Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.9 to 23.7
Stabilization Target: $40.90 (+70.0%)
PE Expansion Potential: +70.0%
Share VCYT Analysis

Share this live VCYT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (VCYT)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits messages suggest bullish sentiment on $VCYT, as one trader believes $VCYT will bottom when Apple (APLD) does. The trader also highlights the company's cash position of $370M and stock repurchase plan of $100M, implying a positive outlook.
Key Retail Themes: Apple's impact on $VCYT Financial position
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 9:20 PM ET
Data refreshes hourly during market hours. Next update: 10:20 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for VCYT.

Create Free Account

Already have an account? Log In

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
GH
Guardant Health Inc
STRONG BUY
26 analysts
$201 52 HOLD
TMO
Thermo Fisher Scientific…
STRONG BUY
27 analysts
$752 54 HOLD
EXAS
EXACT Sciences Corporati…
STRONG BUY
26 analysts
$106 52 HOLD
NTRA
Natera Inc
STRONG BUY
23 analysts
$416 58 HOLD
DHR
Danaher Corporation
STRONG BUY
24 analysts
$260 56 HOLD

Advanced VCYT Option Strategies

Professional options setups generated by AI based on today's VCYT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive VCYT Research Pages
VCYT Technical Chart VCYT Price Prediction VCYT Intrinsic Value DCF VCYT Earnings Date Why is VCYT Moving Today? VCYT Investment Advisor VCYT Fair Price Analyzer VCYT Options Chain VCYT Options Advisor VCYT Options Analysis VCYT Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals